ApolipoproteinA1-75 G/A (M1-) polymorphism and Lipoprotein(a); Anti- vs. Pro-Atherogenic properties

Lipids in Health and Disease

Volumn 6, Issue , 2007, Pages

  Albahrani, Ali I ^a   Usher J, Jannete ^b   Alkindi, Mohammed ^c   Marks, Eileen ^b   Ranganath, L ^b   Al Yahyaee, Said ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; LIPOPROTEIN; ADENINE; GUANINE; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; ATHEROSCLEROSIS; BLOOD; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE DETECTION; HOMOZYGOTE; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

DISEAE;

ADENINE; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; LIPOPROTEIN(A); POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS; TRIGLYCERIDES;

EID: 34848848085     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-6-19     Document Type: Article

References (27)

1. Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum. JF Ascaso A Fernanadez-Cru P Gonazlez Santos A HernandeZ Mijares A Mangas Rojas J Millan L Felipe Pallardo J Pedro-Botet F PereJimene G Pia X Pinto I Plaza J Rubies-Prat, Am J Cardiovasc Drugs 2004 4 299 314 10.2165/00129784-200404050-00003 15449972
2. Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Ck Heng PS Low N Saha, Pediatr Res 2001 49 514 8 10.1203/00006450-200104000- 00013 11264435
3. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. A Pulkkinen L Viitanen A Kareinen S Lehto M Laakso, Diabetes Care 2000 23 791 5 10.2337/diacare.23.6.791 10840998
4. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. JM Ordovas D Corella LA Cupples S Demissie A Kelleher O Coltell PW Wilson FJ Schaefer K Tucker, Am J Clin Nutr 2002 75 38 46 11756058
5. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. M Jeenah A Kessling N Miller S Humphries, Mol Biol Med 1990 7 233 41 1977072
6. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. XL Wang R Badenhop KE Humphrey DE Wilcken, Genet Epidemiol 1996 13 1 10 10.1002/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D 8647374
7. Apolipoprotein A1 gene polymorphisms at the -75 bp and +83/84 bp polymorphic sites in healthy Omanis compared with world populations. SA Al-Yahyaee MN Al-Kindi AI Al-Bahrani, Hum Biol 2004 76 307 12 10.1353/hub.2004.0028 15359539
8. Clustering of cardiovascular risk factors among Omani adults. AA Al Riyami M Afifi, East Mediterr Health J 2003 9 893 903 16450519
9. Increasing prevalence of diabetes mellitus in Oman. Ja Al-Lawati Am Al-Riyami Aj Mohammed P Jousilahti, Diabet Med 2002 19 954 7 10.1046/j.1464-5491.2002.00818.x 12421434
10. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia. AI Al-Bahrani CS Bakhiet RA Bayoumi SA Al-Yahyaee, Diabetes Res Clin Pract 2005 69 44 51 10.1016/j.diabres.2004.09.011 15904989
11. A community-based study of common hereditary blood disorders in Oman. AA Al-Riyami AJ Suleiman M Afifi ZM Al-Lamki S Daar, East Mediterr Health J 2001 7 1004 11 15332742
12. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. C-F Xu F Angelico M Del Ben S Humphries, Genet Epidemiol 1993 10 113 22 10.1002/gepi.1370100204 8339925
13. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. H Paul-Hayase M Rosseneu JP Van Bervliet JP Deslypere SE Humphries, Hum Genet 1992 88 439 46 10.1007/BF00215679 1740321
14. Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults. QH Meng P Pajukanta L Valsta A Aro P Pietinen MJ Tikkanen, J Intern Med 1997 241 373 8 10.1046/j.1365-2796. 1997.122139000.x 9183304
15. G→A substitution at position -75 of the apolipoprotein A-I gene promoter - evidence against a direct effect on HDL cholesterol levels. A Minnich G DeLangavant J Lavigne G Roederer S Lussier-Cacan J Davignon, Arterioscler Thromb Vasc Biol 1995 15 1740 5 7583551
16. Adenine for guanine substitution -78 base pairs to the apolipoprotein (APO) A-I gene: relation with high-density lipoprotein cholesterol and apoA-I concentrations. F Civeira M Pocovi A Cenarro C Garces JM Ordovas, Clin Genet 1993 44 307 12 8131302
17. Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. J Lopez-Miranda JM Ordovas A Espino C Marin J Salas F Lopez-Segura J Jimenez-Pereperez F Perez-Jimenez, Lancet 1994 343 1246 9 10.1016/S0140-6736(94)92149-0 7910273
18. Human apolipoprotein A-I gene promoter mutation influences plasma low-density lipoprotein cholesterol response to dietary fat saturation. P Mata J Lopez-Miranda M Pocovi R Alonso C Lahoz C Marin C Garces A Cenarro F Perez-Jimenez M de Oya JM Ordovas, Atherosclerosis 1998 137 367 76 10.1016/S0021-9150(97)00265-7 9622280
19. Influence of genetic variation at the apoA-I gene locus on lipid levels and response to diet in familial hypercholesterolemia. RF Carmena-Ramon JM Ordovas JF Ascaso J Real MA Priego R Carmena, Atherosclerosis 1998 139 107 13 10.1016/S0021-9150(98)00064-1 9699897
20. Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency. H Akita H Chiba M Tsuji SP Hui Y Takahashi K Matsuno K Kobayashi, Hum Genet 1995 96 521 6 10.1007/BF00197405 8529997
21. Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels. DE Barre R Guerra R Verstraete Z Wang SM Grundy JC Cohen, J Lipid Res 1994 35 1292 6 7964190
22. APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among Northern Indians. S Chhabra R Narang R Lakshmy N Das, Dis Markers 2005 21 169 74 16403951
23. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease. D Petrovic M Zorc B Peterlin, Folia Biol (Praha) 2000 46 181 5 11055796
24. Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls. A Matsunaga J Sasaki T Mori K Moriyama K Nishi K Hidaka K Arakawa, Nutr Metab Cardiovasc Dis 1995 5 269 275
25. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patient with diabetes. T Hiraga T Kobayashi M Okubo K Nakanishi T Sugimoto Ohashi T Murase, Diabetes Care 1995 18 241 244 10.2337/diacare.18.2.241 7729305
26. Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. WY Craig LM Neveux GE Palomaki MM Cleveland JE Haddow, Clin Chem 1998 44 2301 6 9799757
27. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. A Liu R Lawn J Verstuyft E Rubin, J Lipid Res 1994 35 2263 7 7897323